Enliven Therapeutics Correlations

ELVN Stock

27.63 0.22 0.79%

The current 90-days correlation between Enliven Therapeutics and Aston Martin Lagonda is 0.03 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Enliven Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Enliven Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Enliven Therapeutics Correlation With Market

Very weak diversification

The correlation between Enliven Therapeutics and DJI is 0.45 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enliven Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

To learn how to invest in Enliven Stock, please use our How to Invest in Enliven Therapeutics guide.

Moving together with Enliven Stock

0.78	VRDN	Viridian Therapeutics	Pair Corr
0.89	FLGC	Flora Growth Corp	Pair Corr
0.88	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.8	GILD	Gilead Sciences	Pair Corr
0.9	GNFT	Genfit	Pair Corr
0.74	LPCN	Lipocine	Pair Corr
0.92	RNAC	Cartesian Therapeutics Symbol Change	Pair Corr
0.86	RVMD	Revolution Medicines	Pair Corr
0.82	AKRO	Akero Therapeutics	Pair Corr
0.81	ALVO	Alvotech	Pair Corr

Moving against Enliven Stock

0.84	ERNA	Eterna Therapeutics	Pair Corr
0.83	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.75	DYAI	Dyadic International	Pair Corr
0.73	PTN	Palatin Technologies	Pair Corr
0.69	VALN	Valneva SE ADR	Pair Corr
0.63	EVGN	Evogene	Pair Corr
0.32	SLS	Sellas Life Sciences	Pair Corr
0.85	REGN	Regeneron Pharmaceuticals	Pair Corr
0.78	INKT	Mink Therapeutics	Pair Corr
0.72	LYRA	Lyra Therapeutics	Pair Corr
0.66	ONCT	Oncternal Therapeutics	Pair Corr
0.63	KRYS	Krystal Biotech	Pair Corr
0.4	MBIO	Mustang Bio	Pair Corr
0.87	APLS	Apellis Pharmaceuticals	Pair Corr
0.72	AKAN	Akanda Corp	Pair Corr
0.64	AVTR	Avantor	Pair Corr
0.51	AMGN	Amgen Inc	Pair Corr
0.51	SNES	SenesTech	Pair Corr

Related Correlations Analysis

	RGNX	ID	KNF	ARGGY	AMPL	IO	FPCG	KMX	SEIC
RGNX		-0.22	-0.71	0.77	-0.52	0.06	0.0	0.64	-0.8	RGNX
ID	-0.22		0.36	0.03	0.14	0.23	0.0	-0.19	0.23	ID
KNF	-0.71	0.36		-0.49	0.77	0.3	0.0	-0.57	0.89	KNF
ARGGY	0.77	0.03	-0.49		-0.42	0.23	0.0	0.68	-0.65	ARGGY
AMPL	-0.52	0.14	0.77	-0.42		0.33	0.0	-0.59	0.63	AMPL
IO	0.06	0.23	0.3	0.23	0.33		0.0	-0.11	0.07	IO
FPCG	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	FPCG
KMX	0.64	-0.19	-0.57	0.68	-0.59	-0.11	0.0		-0.5	KMX
SEIC	-0.8	0.23	0.89	-0.65	0.63	0.07	0.0	-0.5		SEIC
	RGNX	ID	KNF	ARGGY	AMPL	IO	FPCG	KMX	SEIC

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

SEIC	+ 0.89	KNF
ARGGY	+ 0.77	RGNX
AMPL	+ 0.77	KNF
KMX	+ 0.68	ARGGY
KMX	+ 0.64	RGNX
SEIC	+ 0.63	AMPL

High negative correlations

SEIC	- 0.8	RGNX
KNF	- 0.71	RGNX
SEIC	- 0.65	ARGGY
KMX	- 0.59	AMPL
KMX	- 0.57	KNF
AMPL	- 0.52	RGNX

Risk-Adjusted Indicators

There is a big difference between Enliven Stock performing well and Enliven Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Enliven Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
RGNX	2.80	(0.69)	0.00	(0.30)	0.00	0.00	4.72	(6.48)	15.32
ID	129.57	65.84	1.58	(1.22)	26.88	(206.69)	738.71	(89.19)	1,193
KNF	1.47	0.28	0.16	0.22	1.57	(1.60)	3.38	(3.47)	8.55
ARGGY	2.54	(0.42)	0.00	(0.24)	0.00	0.00	4.12	(5.49)	25.68
AMPL	4.51	0.62	0.10	(1.01)	5.21	(5.40)	11.71	(7.21)	35.68
IO	5.62	(0.02)	(0.01)	0.01	6.67	(6.42)	11.11	(11.92)	40.86
FPCG	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
KMX	1.56	(0.27)	0.00	(0.10)	0.00	0.00	3.38	(3.61)	8.69
SEIC	0.88	0.13	0.10	0.19	1.05	(0.97)	1.85	(1.63)	7.23

Enliven Therapeutics Corporate Executives

Elected by the shareholders, the Enliven Therapeutics' board of directors comprises two types of representatives: Enliven Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Enliven. The board's role is to monitor Enliven Therapeutics' management team and ensure that shareholders' interests are well served. Enliven Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Enliven Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.

Joseph Lyssikatos	CoFounder Officer	Profile
Benjamin Hohl	CFO Development	Profile
Anish PharmD	CoFounder COO	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC